ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0036376;sodium ion export across plasma membrane;9.0;1.0;0.896240625180289;9.628524252492122;131.16583792001737;7.138016298065211;0.004390002553592762;0.7612791106150483;[FXYD2, ATP1B2, ATP1B1, SLC8A1]
GO:0043507;positive regulation of JUN kinase activity;13.0;0.8653626801206646;0.8952363048279688;9.582714716460828;4931.413721535565;5.459585514144159;0.16504997927558432;0.7417584218576596;[IL1RN, TNF, TNFSF11, MAP4K1, EDN1, SYK, RIPK2, MDFIC, IL1B, TLR6, TNFRSF11A, PAK1, CCL19, FZD5, FZD8, CD40LG, PKN1]
GO:0090331;negative regulation of platelet aggregation;10.0;0.9326813400603323;0.8815816818910864;9.601125278304007;548.6740902153413;7.379178354882098;0.01836362802488484;0.7926125360964777;[CEACAM1, PRKCD, CD9, ALOX12]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCH, PRKCD, CCL2, DLL1]
GO:0046854;phosphatidylinositol phosphorylation;8.0;1.0;0.875;9.628524252492122;218.7418113453505;5.049685808968129;0.007321091570879569;0.6332411671050352;[CD86, CD80, PIK3CD, SLA2, PIK3C2A, FGF5, IMPA1, IMPA2, PDGFRB, PDGFRA, CISH, GAB1, TTC7B, VAV1, EREG, BTC, LCK, KIT, PIK3C3, HBEGF, PDGFA, PIK3R3, PIK3R5, SOCS2, CD19, FYN, PIP5K1B, ICOS, TRAT1, EGF, KITLG, PIKFYVE, CD28]
GO:0051490;negative regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.67846133901236;0.005818533269131697;0.8400575416471059;[PRKCD]
GO:0045404;positive regulation of interleukin-4 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[CD86]
GO:0006559;L-phenylalanine catabolic process;10.0;0.9326813400603323;0.8815816818910864;9.59953671561887;1267.4995185646956;7.379178354882098;0.04242206821085258;0.7926125360964777;[IL4I1, ASRGL1]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, ICAM1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, BRIP1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, SUV39H2, ALAS2, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, BIRC2, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, RUVBL2, ADCYAP1, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, CIITA, FHL2, ARRB1, FOXM1, HHEX, PPP1R12A, PEG3, UHRF1, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, CCNC, IKZF1, TNFSF11, HNF1B, SFRP2, EGR1, EGR2, EGR3, IGF1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3D, HNF4A, CD38, IL10, IL18, RGMA, IL1A, IL1B, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, EOMES, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, FOSL2, FOSL1, TGFB1I1, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, EPCAM, NR1H2, NR1H4, GTF2H1, POU4F1, FOSB, PF4, CSF3, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKS1B, KLF13, CKAP2, DCN, DNM2, LEF1, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:2000753;positive regulation of glucosylceramide catabolic process;8.0;1.0;0.875;9.628524252492122;623.5788865307586;9.777073627680469;0.0208706241476218;0.875;[PRKCD]
GO:2000755;positive regulation of sphingomyelin catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;1040.6474307865747;9.777073627680469;0.034829532986543094;0.9152410118609203;[PRKCD]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, ECT2, MED1, TGFB1, JUP, PRKCD, IGF1, MAPK14, IFNG, CDK1, HCLS1]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, RAB31, AGTR1, RIN2, DNMT1, IQGAP3, RASGRP1, RASGRP4, G3BP2, HMOX1, JUN, HACE1, PLK2, DHCR24, IGF1, ARHGAP30, COL1A2, BCL6, CDK2, RGL4, RGL1, LAT, DOCK5, GPSM2, CDKN1A, DOCK4, ARHGAP6, ARHGAP4, RAC2, RALGPS2, ARHGEF12, CHUK, RHOG, RHOH, VAV1, RAB33B, CCNA2, RHOU, DOCK2, AIF1, RAB21, PAK1, NRAS, PDPN, EPS8L1, EPS8L3, DNAJA3]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, PBK, PGLYRP1, IL10, GHSR, GPX1, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, TEK, FCGR2B]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[GPX1, PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, CISH, PRKCB, PRKCD, TSC2, SLA2, PRKCZ, SOCS2, PTPRE, RPS6KB1, IL1B, PRKCQ]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, CCL13, CXCL9, HIST1H2BK, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, GNLY, S100A12, PGLYRP1, CAMP, DEFA4, RNASE6, RNASE3, DEFA1, PPBP, CXCL10, CXCL11, S100A9, LTF, PF4]
GO:0032713;negative regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;7.9853141584524145;0.002174371849661483;0.7314896500084853;[CD83, LEF1]
GO:0035307;positive regulation of protein dephosphorylation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;660.9024749708963;6.063501560976162;0.022119811063664396;0.706328376990269;[PPP1R15A, CDCA2, PDGFRB, PPP1R16B, TGFB1, PPP1R12A, FCRL3, PRKCD, LILRB2, DLC1, CALM3]
GO:0019752;carboxylic acid metabolic process;5.0;0.32428578997777324;0.4523839068498069;5.309370859636751;42.504421911339485;2.9735683700721314;0.0014225847498763097;0.4423094365914798;[, ENO2, IL4I1, AKT1, CYP1B1, UPB1, CH25H, MTHFD1, PADI4, ACMSD, C3, PRKAR2B, CYP4F2, CYP4F3, DHFR, SLC6A6, FA2H, BHMT, NOX4, DPYS, PFAS, ATIC, ELOVL4, ARG1, BGN, ELOVL6, ELOVL7, SLC7A5, SLC7A7, SLC7A8, DPYD, ACSBG1, GART, AOAH, PTGS2, PTGS1, ALOX5, NR1H4, AGMAT, PLP1, HNMT, SLC16A3, UGT2B15, UGT2B17, PGD, SLC27A3, SLC27A2, GMPS, HMMR, ACAT1, OSBPL7, AGXT2, CYP4F12, P4HA2, TBXAS1, CSPG4, SERINC5, ETFA, SCPEP1, DSE, UGT2A3, GPX1, BPGM, TST, BCAT1, ASPA, UGT2B28, CYP3A4, SLC25A21, IL1RN, ACSM5, MCCC2, ACSL1, ACSL5, MIF, ASRGL1, POR, SUCLG1, MGST1, PKHD1, IGF1, HAL, ALDH6A1, VNN1, VNN2, VNN3, ALDH18A1, HIBADH, TECR, BRCA1, HNF4A, ACADM, EDN1, SYK, IL15, BHMT2, IL1B, TLR2, HSD17B4, NPL, TYMS, CD74, GCH1, PNPLA8, NDUFAB1, SCARB2, CPOX, KMO, SLC1A3, ALOX12, GLYAT, TGFB1, GGH, NR4A3, ACSM2A, GHR, HK3, KYNU, HIBCH, CYP4A11, CAD, PRODH2, DCN, VCAN, NDUFS6, EHHADH, SLC3A1, SNCA, MAPK14, SCD]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GPX1, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP3, DUSP1, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0090398;cellular senescence;4.0;0.8653626801206646;0.6826813400603323;9.446202695698167;55.136139509281044;6.343086423195323;0.0018453569700716361;0.5743857346658935;[CDKN1A, PRKCD, H2AFX, HMGA1, MAPK14, SIRT1, PML]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, TGM2, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:0043488;regulation of mRNA stability;9.0;0.7436939687323844;0.7680876095464813;9.240758721483358;282.23354693635815;4.989581884898423;0.009446102822258332;0.6514080748132811;[FMR1, XPO1, AKT1, SLC11A1, PRKCD, AXIN2, E2F1, RBM38, TNFSF13, MAPK14, MYD88]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, PLCG2, NCKAP1L, FYN, PLCG1, FCGR1A, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, RELB, PAK1, NRAS, KLRK1, PLCG2, MUC13, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4A, CLEC4D, CLEC4E, CARD11]
GO:0030007;cellular potassium ion homeostasis;9.0;0.9326813400603323;0.8625812952104552;9.574457031221845;285.76071857591336;7.138016298065211;0.009564154082785858;0.7612791106150483;[ATP1B2, ATP1B1]
GO:0043372;positive regulation of CD4-positive, alpha-beta T cell differentiation;11.0;0.7980440201809971;0.8314509624201607;9.541512875502493;1782.7320683291834;6.409777797693995;0.0596664379722798;0.7602252869888839;[CD86, CD83, ANXA1, RIPK2, CD80, IL18, PRKCZ, IFNG, IL23A, HLX, MYB, RARA, NLRP3, NCKAP1L, CCL19, IL12RB1, NFKBID]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[, TNF, AKT1, PROK2, TNFSF11, MAP3K8, PRKACB, MAP2K2, SLC11A1, F2R, PRKCD, PRKAR1B, ADAM9, CALCA, C5AR1, FPR1, TGFA, ADRB2, IQGAP3, PRKCZ, PRKAR2B, PDGFC, NCKAP1L, CLSPN, ECT2, DRD4, MAP2K6, TGFB2, GADD45B, TNFRSF10B, EIF2AK2, IGF1, TPX2, BMP2, CDK1, CSPG4, LRRK2, ITGB3, KIF14, ARRB1, GHR, MAP4K1, SYK, RIPK2, STRADB, IL18, EMP2, DUSP6, GREM1, MDFIC, IL1B, KIT, CHI3L1, TLR6, TLR4, CXCR4, NOD2, THBS1, PAK1, NTF3, CCL19, CD74, EGF, MAPK14, CD40LG, PKN1]
GO:0086064;cell communication by electrical coupling involved in cardiac conduction;4.0;0.8259837884571596;0.6629918942285797;8.935377071932177;22.009319849728328;7.138016298065211;7.366321282685284E-4;0.6150384854347593;[GJC1, FKBP1B, ATP1B2, ATP1B1, SLC8A1]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[THY1, PRKCZ, SAMSN1, PPP2R1A, NTF3, CAV1, PRKCD, SFRP2, PTPN6]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, MAP3K8, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:1903278;positive regulation of sodium ion export across plasma membrane;10.0;1.0;0.9152410118609203;9.628524252492122;363.3657930958667;8.390779266560578;0.012161526086936028;0.8443458537639685;[ATP1B2, ATP1B1]
GO:1900163;positive regulation of phospholipid scramblase activity;9.0;1.0;0.896240625180289;9.628524252492122;406.95467434623936;9.777073627680469;0.013620406714939737;0.896240625180289;[PRKCD]
GO:0032781;positive regulation of ATPase activity;6.0;0.7508913569872202;0.6985659910837546;8.781226392104918;51.416896668601964;5.8067817141283475;0.0017208772592953517;0.6200793994936333;[NAPA, UHRF1, NCAPH, TPM1, ATP1B2, ATP1B1, DNM2, PLSCR1, DNAJC9, PFN1]
GO:0044861;protein transport into plasma membrane raft;11.0;1.0;0.9324289523296623;9.628524252492122;279.98422179103943;9.083926447120524;0.009370819933905719;0.8969813732811862;[ATP1B1]
GO:0014050;negative regulation of glutamate secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;415.4544886335298;7.8311634786251565;0.013904887849799128;0.7967266896635242;[IL1RN, IL1B]
GO:0043017;positive regulation of lymphotoxin A biosynthetic process;8.0;1.0;0.875;9.628524252492122;856.0759792352393;9.777073627680469;0.028652092606641942;0.875;[CD86]
GO:0001660;fever generation;7.0;1.0;0.8509193652572005;9.628524252492122;35.726156595412796;8.16763571524637;0.0011957223097949796;0.7686126355688037;[IL1A, IL1RN, IL1B]
GO:1901018;positive regulation of potassium ion transmembrane transporter activity;10.0;0.7671156992804218;0.7987988615011312;9.418803721510052;727.157729141708;6.7325511899570465;0.02433731479490395;0.7595439928109722;[ATP1B2, ATP1B1, DNM2]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0010248;establishment or maintenance of transmembrane electrochemical gradient;6.0;1.0;0.8231203125901445;9.628524252492122;27.942148572769092;7.212124270218933;9.351985664295021E-4;0.6919486831672181;[FXYD2, ATP1B2, ATP1B1]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PDE4D, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A9, S100A8, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, FUT7, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, PDE4D, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, F2RL1, PTPN6, TEK, CD244, PF4]
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;8.16763571524637;0.010250602759086841;0.7926932703116032;[IL6, IL1RN, IL1R2]
GO:2000304;positive regulation of ceramide biosynthetic process;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;909.7864372675522;7.57984905034425;0.03044973330070948;0.7838744581139225;[PRKCD, TNF, CYR61]
GO:0010882;regulation of cardiac muscle contraction by calcium ion signaling;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;68.46878113000767;6.641579411751319;0.0022915884865189126;0.7358913051622797;[CAMK2D, PLN, FKBP1B, DMD, CALM3, ATP1B1, SLC8A1]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, ITGAM, PRKCD, ITGB2, F2RL1, FPR2, GNAI2, CD177]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[PYCARD, PPP2R1A, PRKCD, MAL, S100A9, ATF3, S100A8, NACC2, TP53BP2, SFN, TNFSF12, CAV1, INHBA, BCL2, NOX1, ITM2C, BCL2L1, SRPX, PLEKHF1, CTSH, TIMP3, CASP2, YWHAH, PLAUR, MMP9, SIRT1, TFDP1, LCK, THBS1, E2F1, CTNNA1, GSN, BIK, G0S2, GZMB, PML, PPP1CA, LTBR]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, SLA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, RIPK2, IL15, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, TTK, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[IL1RN, ANXA1, HNF1B, ADCYAP1, FKBP1B]
GO:1903288;positive regulation of potassium ion import;10.0;1.0;0.9152410118609203;9.628524252492122;414.29394802332047;8.67846133901236;0.01386604559999416;0.8590579283277371;[ATP1B2, ATP1B1]
GO:0006883;cellular sodium ion homeostasis;9.0;1.0;0.896240625180289;9.628524252492122;285.76071857591336;6.8867018697843045;0.009564154082785858;0.7484268790654467;[C7, NEDD4L, ATP1B2, ATP1B1, SLC8A1]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRRK2, CTSZ, ARRB2, IFIT1, IFIT2, RUVBL2, STMN1, AKT1, IL10, ITGA4, PRKCD, AES, SLPI, LEF1, ADRB2, AURKB, AURKA, EPB41L5, CCL23, CAV1, EIF2S1, PPP1CA, DAB2, ID1, CAMK1]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[F11R, ICAM1, TIAM2, DEPDC1B, RIN2, LLGL2, EPHA2, THY1, RACGAP1, NCKAP1L, A2M, JUN, EZH2, ARHGAP9, DENND1B, NRP1, CD40, ARHGAP6, ARHGAP4, CCR7, RHOG, GMIP, VAV1, DEPDC1, PLCB1, CCL13, NTF3, CCL19, CCL18, RANBP2, RANBP1, CCL23, CCL21, CCL20, DLC1, F2RL1, SIPA1, CXCL13, RGS1, ARHGDIA, ARHGDIB, F2R, TSC2, ADCYAP1, ACAP1, PRTN3, ARHGAP19, RASAL2, ARHGAP15, RASGRP1, ADAP2, ECT2, EVI5, CAV2, ARHGAP25, TBCK, ARHGAP30, GNAQ, ARHGAP11A, DOCK4, LRRK2, ARRB1, TAGAP, ARHGEF12, TBC1D8, TBC1D9, ARAP3, ARAP1, AXIN2, ALDH1A1, XCL2, XCL1, DOCK2, ASAP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, IL10, ANXA1, FCER1G, SYK, PDE4D, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:0023021;termination of signal transduction;7.0;0.8653626801206646;0.7836007053175329;9.434368238051164;144.8699869040881;8.67846133901236;0.004848668087156246;0.7947362817240173;[PRKCD]
GO:0002439;chronic inflammatory response to antigenic stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;42.97336350789415;8.390779266560578;0.0014382798030929574;0.7522251544931926;[IL1RN, IL1B, TNF]
GO:0016572;histone phosphorylation;8.0;0.7090535922965819;0.729526796148291;9.195660170195843;367.80445225036385;6.444869117505266;0.012310084014303157;0.7045909063862833;[PRKCB, PRKCD, VRK1, AURKB, AURKA, CCNA2, CCNB1, CHEK1, CDK2, CDK1, PKN1]
GO:1903281;positive regulation of calcium:sodium antiporter activity;11.0;1.0;0.9324289523296623;9.628524252492122;1610.6520007917477;9.083926447120524;0.05390707297380812;0.8969813732811862;[ATP1B1]
GO:1904385;cellular response to angiotensin;8.0;1.0;0.875;9.628524252492122;462.69925393661634;7.379178354882098;0.015486127626965131;0.7523715242355574;[BRIP1, PRKCD, CDC6, SLC30A10, NFKB1]
GO:2001022;positive regulation of response to DNA damage stimulus;7.0;0.7043150770688792;0.7030769037916401;8.890925309361343;86.91339641844894;5.382624473008031;0.0029089131611469855;0.6261870311244675;[BLM, PCNA, FMR1, BRCA1, FOXM1, NACC2, APBB1, PRKCD, H2AFX, PARP9, SIRT1, TIMELESS]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, PIK3R5, C3, GNG10, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD2, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, GNG11, MARCO, PNOC, CALM3, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, EDN1, GPR37, ANXA1, GPR35, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, PLCB1, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR3, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, F2RL1, RAMP1, LGR4, F2RL3, PF4, CHRM2, FCN1, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, CISH, SPNS3, APLP2, F2R, NPY1R, DGKZ, PDGFRL, ADCYAP1, SPNS1, OR2C3, GNAZ, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, GNAQ, OR7E24, TAS2R7, CXCL6, GPSM2, CXCL9, OR1G1, PLEK, CXCL1, ARRB1, ARRB2, CXCL3, CXCL2, CXCL5, LTB4R, GRM5, CA2, PDE4B, PTGIR, ARHGEF12, PDE4D, GLP2R, OR2H1, XCL2, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, GNA15, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, LEF1, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PGLYRP1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, CFP, GNS, C3, S100A12, NCKAP1L, ELANE, S100A11, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, NRAS, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, RAB31, ADAM8, SLC27A2, S100A9, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, NPC2, PECAM1, BPI, ACPP, FGL2, TTR, CPPED1, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CTSD, CAMP, CD33, CTSB, CD53, CCT2, FCER1G, MME, GAA, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, GCA, LILRB2, LILRB3, QPCT, CD68, FCN1, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, CYBB, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, GGH, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, DOCK2, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, EBI3, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, IGF1, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[SPARC, TFRC, CLEC10A, ICAM3, KIAA1109, DPYSL2, CUBN, SLC11A1, HSPG2, RIN2, CFI, FPR2, CD14, IGHA1, ELANE, SLAMF1, MSR1, CDC7, MARCO, DENND1B, ACHE, ADM, CLINT1, ASGR1, ASGR2, STAB1, CD36, ANXA1, FCER1G, SYK, ANXA3, NME1, CEACAM1, RARA, RHOU, CD302, CD5L, TMPRSS2, IGKC, CXCR1, CXCR2, SORT1, LILRB1, SNX17, NEDD4, SIGLEC1, RAMP1, SCARB2, NCF2, NCF4, HP, LY75, CXCL16, LOXL2, PYCARD, AP2M1, TGM2, CD93, TSC2, RAB31, PRTN3, CALCRL, PLD4, ADRB2, CORO1A, IGLV1-44, CD163, SYT2, CAV2, CAV1, LRP1B, MARCH3, DAB2, SYNJ1, IGKV3-20, LRP12, BCL2L1, LRRK2, ITGB3, ITGB2, ARRB1, ARRB2, ITGAL, PIK3C2A, GHR, ITGA4, DNM2, PECAM1, IRF8, PIK3C3, DOCK2, COLEC12, NLGN1, LRP1, CEBPE, LRP2, DLL1, FCGR1A, FCGR1B, ATP9A, SNCA, NLGN4Y, CD6, CD5, CD9, FCGR2B]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, PGLYRP1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, HLA-E, CLEC4D, SLPI, IL23A, CLEC4E, S100A9, S100A8, SEH1L, C5AR1, CFP, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, RIPK2, TLR1, FGR, IGHD, LTA, IRF8, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:1990573;potassium ion import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;262.9545538247555;7.57984905034425;0.008800852272780338;0.8200627852632958;[FXYD2, ATP1B1]
GO:0046034;ATP metabolic process;10.0;0.6519675769143192;0.7412248003180799;9.106334870075816;1262.3387643731025;4.99795013456894;0.04224934241243719;0.6708364141712261;[ENO2, HK3, BPGM, ATP1B1, ATP5J2, ADCYAP1, MSH2, UQCRC1, FAM20C, UQCRC2, UQCRB, ATP5J, ATP5I, ATP5H, ATP5O, COX5B, UQCRH, ATP5L, FIGNL1, CYC1, TGFB1]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36, AIF1]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, NBL1, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, IGF1, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL15, PDE4D, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0032079;positive regulation of endodeoxyribonuclease activity;9.0;1.0;0.896240625180289;9.628524252492122;975.1149925155983;8.390779266560578;0.03263622125297896;0.8253454670833372;[PRKCD, AKT1]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, RIPK2, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, SIGLEC16, CARD9, LILRB2, MAPK13, IL6, F2RL1, MYD88, IL17A]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, CLSPN, PLK2, PLK1, CDC7, CLK1, CDK2, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, TTK, AURKB, AURKA, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, IFITM1, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, NBL1, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCB, PRKCD, CAD, VRK1, CAMK2D, TTK, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, EMP2, ATP1B1, ANK1, RAB31, PKP3, TSPAN33, PRKCZ, EPB41L3, FLNA, TSPAN5, JUP, KCNIP4, TSPAN15, EHD3, RAMP1]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[SCARB2, CD86, TFRC, ITGB5, CD80, ITGB3, F11R, ICAM1, ANPEP, CLEC5A, ITGB7, ITGB6, HAVCR1, CTSB, CR2, CR1, CXADR, EPHA2, GYPA, SELPLG, DPP4, NCAM1, SLAMF1, GPR15, CDK1]
GO:0086013;membrane repolarization during cardiac muscle cell action potential;8.0;0.811012628672052;0.780506314336026;9.249034630787218;81.641259119529;7.004484905440688;0.0027324594703676576;0.7332096838060964;[KCNH2, KCNQ1, KCNA5, ATP1B1]
GO:0071874;cellular response to norepinephrine stimulus;8.0;1.0;0.875;9.628524252492122;410.2922764159275;8.67846133901236;0.01373211325256535;0.8188169164668168;[IL1RN]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0032743;positive regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.409777797693995;0.002183412136085803;0.6509166472493662;[CD86, CD83, CD80, CD3E, PDE4B, CCR2, ANXA1, RIPK2, PDE4D, IL1A, CD4, IL1B, CD28, PRKCQ, CARD11]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, ICAM1, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, HCK, IFNG, OAS1, OAS3, IRF7, IRF8, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, STAT1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, ADM, PRL, ETS1, THBD, CD38, TGFB1, IGFBP5, CAD, FOS, FOSL1, ADCYAP1, CLDN4, PNOC, RARA, BCL2, FOSB]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[CD86, RARA, IL18, NLRP3, PRKCZ]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, TGM2, PDGFRA, PRKCE, F2R, ATP1B1, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, PKHD1, CD19, HRH4, PLCG2, PLCG1, ELANE, CCR10, DRD4, CCR1, TGFB1, WFS1, VDR, CAV1, CXCL10, CXCL11, CXCL12, PTPRC, BCL2, CALM3, CD24, GPR18, CXCL9, CD40, ATP2A3, FASLG, ADM, GRM5, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, TRPC7, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, SLC24A2, SLC24A1, CCL13, SLC24A4, CAMK2D, PTGER2, CXCR5, CXCR4, KCNA5, CXCR6, ATP2C2, GNA15, CCL8, PLN, CXCR1, CCL7, SV2A, CCL5, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL23, CCL21, TMEM64, GPR6, PML, P2RX5, CD4, XK, FKBP1B, F2RL1, GRINA, F2RL3]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, IL1A, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CD80, GFI1, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, ICAM1, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, PDE4D, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, IRF8, TLR4, CX3CR1, CD274, CEBPB, CEBPE, SBNO2, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, TNIP3, PF4]
GO:0030837;negative regulation of actin filament polymerization;11.0;0.8436909121759173;0.8542744084176208;9.536150932361107;433.7598075732239;5.8067817141283475;0.014517550400993206;0.7293880392331511;[LMOD1, CAPG, EPS8, SPTA1, SPTAN1, TMOD1, GSN, PRKCD, SPTB, VIL1, PFN1]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CEBPB, CD80, IHH, LRRC32, GPNMB, CTLA4, HAVCR2, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, HLA-G, XCL1, PTPN6, PDE5A, MAD1L1]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0070098;chemokine-mediated signaling pathway;7.0;0.7307253602413294;0.7162820453778652;8.999915593069748;30.19135422731818;5.459585514144159;0.00101047745553359;0.6301228223472235;[CX3CR1, CXCL6, CCL13, CXCL9, CXCR5, MPL, CXCR4, CXCL1, CXCR6, CXCL13, CXCL3, CXCL2, CXCL5, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCRL2, CCL4, CCR9, CCL2, CCL1, CCR7, CCR6, CCL19, CCR5, CCL18, CCR10, CCR3, CCR2, CCR1, CCL23, CCL21, CCL20, GPR35, PPBP, CXCL10, CXCL11, CXCL12, XCL2, XCL1, PF4]
GO:0034115;negative regulation of heterotypic cell-cell adhesion;8.0;1.0;0.875;9.628524252492122;130.132988179366;7.57984905034425;0.004355434002277579;0.7626338329336335;[IL10, IL1RN, KLF4]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[IL1RN, NOD2, MAP3K8, EGR1, CHUK, IL1R1, RIPK2, IL1R2, IRAK3, NFKB1, NFKBIA, IL1A, IL1B, PLCB1, MYD88]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
